Explanipedia

S8 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Parth R. Majmudar, Amy Aponte, Ran Zhao, Kristen L. Weber-Bonk, Fadi W. Abdul‐Karim , et al. · 2025

Supplemental Figure 8 Legend

S3 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Parth R. Majmudar, Amy Aponte, Salendra Singh, Kristen L. Weber-Bonk , et al. · 2025

Supplemental Figure 3 Legend

S2 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Amy Aponte, Ran Zhao, Kristen L. Weber-Bonk, Fadi W. Abdul‐Karim , et al. · 2025

Supplemental Figure 2

S6 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Parth R. Majmudar, Amy Aponte, Salendra Singh, Ran Zhao , et al. · 2025

Supplemental Figure 6

S7 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Parth R. Majmudar, Amy Aponte, Salendra Singh, Ran Zhao , et al. · 2025

Supplemental Figure 7

S3 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Parth R. Majmudar, Amy Aponte, Salendra Singh, Ran Zhao, Kristen L. Weber-Bonk , et al. · 2025

Supplemental Figure 3

S7 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Amy Aponte, Salendra Singh, Ran Zhao, Kristen L. Weber-Bonk , et al. · 2025

Supplemental Figure 7 Legend

S6 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Parth R. Majmudar, Amy Aponte, Ran Zhao, Kristen L. Weber-Bonk, Fadi W. Abdul‐Karim , et al. · 2025

Supplemental Figure 6 Legend

S5 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open

Lindsey J. Anstine, Parth R. Majmudar, Amy Aponte, Salendra Singh, Ran Zhao , et al. · 2025

Supplemental Figure 5

Spatial multiomics of human hepatic lymph nodes reveals early APC bifurcation in liver transplant rejection Open

Justin H. Nguyen, Haseem Ashraf, Raymond M. Moore, William H. Sherman, Yaohua Ma , et al. · 2025

The highest risk for liver allograft rejection is within the first weeks to months after a liver transplant; however, while later-stage mechanisms are well described, the initial window at the moment of alloantigen influx (e.g., ~ 1 h post…

Torso synthetic CT generation by integrating deep learning and segmentation for FDG-PET/MR attenuation correction Open

Jin Uk Heo, Shujin Sun, Robert S. Jones, Yi Gu, Yizhang Jiang , et al. · 2025

Introduction. Positron Emission Tomography/Magnetic Resonance ( PET/MR ) offers benefits over PET/CT including simultaneous PET and MR acquisition, intrinsic spatial registration accuracy, MR-based functional information, and superior soft…

Epigenetic aging differentially impacts breast cancer risk by self-reported race Open

Yanning Wu, Megan E. Miller, Hannah Gilmore, Cheryl L. Thompson, Fredrick R. Schumacher · 2024

Background Breast cancer (BrCa) is the most common cancer for women globally. BrCa incidence varies by age and differs between racial groups, with Black women having an earlier age of onset and higher mortality compared to White women. The…

The distribution of esophageal cancer patients enrolled in care at the Uganda Cancer Institute by sub-regions, districts and ethnicity Open

Siraji Obayo, Yusuf Mulumba, Cheryl L. Thompson, Michael K. Gibson, Matthew M. Cooney , et al. · 2024

Background: There is limited published data regarding the distribution of esophageal cancer patients by sub-regions, districtsand ethnicity in Uganda. Objectives: To study the distribution by sub-regions, districts, ethnicity and sub-regio…

Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy Open

Dan Lin, Kathleen M. Sturgeon, Joshua Muscat, Shouhao Zhou, Andréa L. Hobkirk , et al. · 2024

The promise and challenges of multi-cancer early detection assays for reducing cancer disparities Open

Cheryl L. Thompson, Monica L. Baskin · 2024

Since improvements in cancer screening, diagnosis, and therapeutics, cancer disparities have existed. Marginalized populations (e.g., racial and ethnic minorities, sexual and gender minorities, lower-income individuals, those living in rur…

Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials Open

Cheryl L. Thompson, Adam H. Buchanan, Ronald E. Myers, David S. Weinberg · 2024

Effective implementation of cancer screening programs can reduce disease-specific incidence and mortality. Screening is currently recommended for breast, cervical, colorectal and lung cancer. However, initial and repeat adherence to screen…

Associations Between Leisure-Time Physical Activity Level and Peripheral Immune Cell Populations in the US General Population, Analysis of the National Health and Nutrition Examination Survey Data, 1999–2018 Open

Dan Lin, Cheryl L. Thompson, Djibril M. Ba, Joshua Muscat, Shouhao Zhou , et al. · 2023

Clinicopathological characteristics and treatment outcomes of oesophageal cancer patients in Uganda Open

Siraji Obayo, Yusuf Mulumba, Cheryl L. Thompson, Michael K. Gibson, Matthew M. Cooney , et al. · 2023

Treatment outcomes of Ugandan oesophageal cancer patients seeking care are poor as most patients present with advanced disease. There is a significant loss of follow-up after treatment initiation. Therefore, reduction in exposure to known …

Table S1 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis Open